GELS
Gelteq Limited Ordinary Shares NASDAQ Listed Oct 29, 2024$0.56
-2.56%
vs $0.57
Mkt Cap $5.1M
52w Low $0.39
10.3% of range
52w High $2.02
50d MA $0.61
200d MA $0.75
P/E (TTM)
—
EV/EBITDA
—
P/B
—
Debt/Equity
0.3x
ROE
—
P/FCF
—
RSI (14)
43.00
ATR (14)
$0.05
Beta
0.04
50d MA
$0.61
200d MA
$0.75
Avg Volume
69.4K
Gelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals. It offers white label gel-based delivery solutions for prescription drugs, over-the-counter products, nutraceuticals and sports, pet care, and other products. The company was incorporated in 2017 and is headquartered in Caulfield, Australia.
641 Glen Huntly Road · Caulfield, VIC 3162 · AU
Data updated apr 25, 2026 11:07am
· Source: financialmodelingprep.com